Ever Source Wealth Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 100 shares of BCRX stock, worth $762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$762
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$143 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$95.8 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$71.2 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$67.3 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.42B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...